Early local antitoxin intervention attenuates botulinum neurotoxin-induced neuromuscular dysfunction

Area of Science:

• Neuroscience
• Pharmacology
• Toxicology

Background:

• Botulinum neurotoxin type A (BoNT/A) is clinically significant but can cause unintended muscle dysfunction.
• Current management for BoNT/A-induced impairment relies on observation due to lack of pharmacological options.

Purpose of the Study:

• To investigate the efficacy of local serum antitoxin administration in counteracting BoNT/A-induced neuromuscular dysfunction.
• To determine the optimal temporal window for effective antitoxin intervention.

Main Methods:

• Rats received intramuscular BoNT/A followed by local antitoxin serum at varying time points (0-144 h).
• Neuromuscular function (CMAPs) and muscle atrophy were assessed in rats.
• Mice received high-dose BoNT/A simulating clinical misinjection, with antitoxin administered at 0-48 h.
• Muscle function (DAS) and atrophy were evaluated in mice.

Main Results:

• Antitoxin administration within 24 hours (rats) or 16 hours (mice) significantly attenuated BoNT/A effects.
• Delayed treatment (≥48 hours) showed no therapeutic benefit.
• Early intervention improved muscle function and reduced atrophy, with some benefit observed even after initial impairment onset.

Conclusions:

• Local antitoxin serum is effective in limiting BoNT/A-induced neuromuscular dysfunction when administered within a critical, short time window.
• Therapeutic effects are time-dependent, with early intervention crucial for optimal functional recovery.
• Findings support antitoxin as a potential treatment for unintended BoNT/A exposure, warranting further clinical validation.